Simple Summary Historically, cancers presenting with their main tumor mass in the ovary
have been classified as ovarian carcinomas (a concise term for epithelial ovarian cancer) …

Abstract Background Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic
target in tubo‐ovarian high‐grade serous carcinoma (HGSC). Smaller studies have revealed …

Purpose: The purpose of this study was to evaluate RB1 expression and survival across
ovarian carcinoma histotypes and how co-occurrence of BRCA1 or BRCA2 (BRCA) …

Odontogenic cysts are a diverse group of pathologic entities with different proliferation
potential, leading to variations in their biological behavior. One of the most cited proliferation …

Background: Previous studies have shown that MCM3 plays a key role in initiating DNA
replication. However, the mechanism of MCM3 function in most cancers is still unknown. The …

Objective Inhibition of the MAPK pathway by MEK inhibitors (MEKi) is currently a therapeutic
standard in several cancer types, including ovarian low-grade serous carcinoma (LGSC). A …

Objective We aimed to screen novel gene signatures for ovarian cancer (OC) and explore
the role of biomarkers in OC via regulating pyroptosis using bioinformatics analysis …

Background Recently, we showed a> 60% difference in 5-year survival for patients with tubo-
ovarian high-grade serous carcinoma (HGSC) when stratified by a 101-gene mRNA …

The dynamics of more than 1900 mitochondrial proteins was explored through quantitative
proteomics in 151 melanoma-related tissue samples of both surgical and autopsy origin …

Intratumoral heterogeneity (ITH) is spatial, phenotypic, or molecular differences within the
same tumor that have important implications for accurate tumor classification and …